02 9541 3500
Characterising Lipid Nanoparticles for Vaccine Development
Lipid nanoparticles (LNPs) either loaded with nucleic acids or as liposomes containing an aqueous core,
The Role of Lipid Nanoparticles in Vaccine Development
The recent approval of COVID vaccines from Moderna and Pfizer based on mRNA-containing lipid nanoparticles
Engineering Vaccine Delivery: Fundamentals Of Creating Lipid Nanoparticles And Liposomes For Encapsulating Therapeutic Drug Molecules.
The terms Liposome and Lipid Nano Particle (LNP) are coined interchangeably. Whilst they are quite similar,
New T Cell Therapy reagent for mRNA delivery using Lipid Nanoparticles
Precision NanoSystems is proud to announce that the GenVoy-ILM™ T Cell Kit for mRNA is now available
WHITEPAPER: A Better Way to Create Nanoparticles for in vivo Treatments.
By Peter Davis The production of technologies, like most things, is not immune to imperfection, and sure
Effects of Polymeric and Lipid Nanoparticle Self Amplifying RNA Formulation on Protein Expression and Vaccine Immunology, presented by Dr. Anna Blakney
You may be asking, who is Dr Anna Blakney?Dr Anna Blakney, Assistant Professor at The University of British
Discover the latest in Microfluidic Mixing for rapid, reproducible and scalable manufacture of novel nanoparticles.
Heading to the 9th International Nanomedicine Conference – 25-27 June 2018? ATA Scientific is the
The Key Considerations For Developing Lnps As Drug Delivery Vehicles.
Lipid Nanoparticles (LNPs) continue to grow in popularity as they enable the efficient delivery of therapeutic
Next Generation LNP Manufacturing
Ease of scalability Producing COVID-19 vaccines for the entire world population rapidly demonstrated the